Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer
Abstract Cancer cells often upregulate nutrient transporters to fulfill their increased biosynthetic and bioenergetic needs, and to maintain redox homeostasis. One nutrient transporter frequently overexpressed in human cancers is the cystine/glutamate antiporter solute carrier family 7 member 11 (SL...
Main Authors: | Pranavi Koppula, Yilei Zhang, Li Zhuang, Boyi Gan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-04-01
|
Series: | Cancer Communications |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40880-018-0288-x |
Similar Items
-
Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy
by: Pranavi Koppula, et al.
Published: (2020-10-01) -
NADPH debt drives redox bankruptcy: SLC7A11/xCT-mediated cystine uptake as a double-edged sword in cellular redox regulation
by: Xiaoguang Liu, et al.
Published: (2021-11-01) -
Production of recombinant human xCT (SLC7A11) and reconstitution in proteoliposomes for functional studies
by: Michele Galluccio, et al.
Published: (2022-09-01) -
CIC reduces xCT/SLC7A11 expression and glutamate release in glioma
by: Jong-Whi Park, et al.
Published: (2023-01-01) -
The role of glutamine synthetase expression and cystine/glutamate transporter (SLC7A11, xCT) in epilepsy pathogenesis of patients with supratentorial brain gliomas
by: M. Yu. Prokudin, et al.
Published: (2022-07-01)